A Multimarker Approach for the Prediction of Coronary Artery Disease: Cost-Effectiveness Analysis

Author： Lakić Dragana   Bogavac-Stanojević Nataša   Jelić-Ivanović Zorana   Kotur-Stevuljević Jelena   Spasić Slavica   Kos Mitja  

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.6, 2010-09, pp. : 770-777

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis for Statin Therapies in the Primary Prevention of Coronary Heart Disease in Italy

By Berto P.  

Clinical Drug Investigation, Vol. 20, Iss. 2, 2000-08 ,pp. : 109-121

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Treatments to Reduce Cholesterol Levels, Blood Pressure and Smoking for the Prevention of Coronary Heart Disease: Evaluative Study Carried Out in Spain

By Plans-Rubió P.  

PharmacoEconomics, Vol. 13, Iss. 5, 1998-05 ,pp. : 623-643

Adis International

Access to resources Recommend Favorite

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine   Shabaruddin Fatiha H  

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

Cost Effectiveness of HMG-CoA Reductase Inhibitors in the Management of Coronary Artery Disease: The Problem of Under-Treatment

By McCabe C.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 3, 2003-01 ,pp. : 179-191

Adis International

Access to resources Recommend Favorite

Health Utilities in Alzheimer’s Disease and Implications for Cost-Effectiveness Analysis

By Neumann Peter J.  

PharmacoEconomics, Vol. 23, Iss. 6, 2005-01 ,pp. : 537-541

Adis International

Access to resources Recommend Favorite